{"id":19666,"date":"2022-04-08T09:49:17","date_gmt":"2022-04-08T13:49:17","guid":{"rendered":"https:\/\/medicarereport.org\/?p=19666"},"modified":"2022-04-08T09:50:24","modified_gmt":"2022-04-08T13:50:24","slug":"medicare-finalizes-its-restrictions-on-new-alzheimers-drug-despite-pressure-from-drugmakers","status":"publish","type":"post","link":"https:\/\/medicarereport.org\/?p=19666","title":{"rendered":"Medicare finalizes its restrictions on new Alzheimer\u2019s drug, despite pressure from drugmakers"},"content":{"rendered":"\n<p>(By Rachel Cohrs for ST<em>A<\/em>T)<\/p>\n\n\n\n<p>WASHINGTON \u2014 Medicare on Thursday finalized its plan to restrict coverage for the controversial, pricey Alzheimer\u2019s drug Aduhelm to patients participating in clinical trials.  Continue reading <a href=\"https:\/\/www.statnews.com\/2022\/04\/07\/medicare-final-decision-alzheimers-coverage-biogen-aduhelm\/\" data-type=\"URL\" data-id=\"https:\/\/www.statnews.com\/2022\/04\/07\/medicare-final-decision-alzheimers-coverage-biogen-aduhelm\/\">here&#8230;<\/a><\/p>\n\n\n\n<p><img loading=\"lazy\" decoding=\"async\" width=\"200\" height=\"21\" class=\"wp-image-4372\" style=\"width: 200px;\" src=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png\" alt=\"\" srcset=\"https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo.png 453w, https:\/\/medicarereport.org\/wp-content\/uploads\/2016\/09\/STAT-Logo-300x32.png 300w\" sizes=\"auto, (max-width: 200px) 100vw, 200px\" \/><\/p>\n\n\n\n<p class=\"has-small-font-size\"><strong>Notice<\/strong>: The\u00a0link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; socialsecurityreport.org cannot guarantee the duration of the link\u2019s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or socialsecurityreport.org.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(By Rachel Cohrs for STAT) WASHINGTON \u2014 Medicare on Thursday finalized its plan to restrict coverage for the controversial, pricey<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26,6,15],"tags":[],"class_list":["post-19666","post","type-post","status-publish","format-standard","hentry","category-alzheimersdementia","category-medicare-general","category-part-dprescription-drugs"],"_links":{"self":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/19666","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=19666"}],"version-history":[{"count":2,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/19666\/revisions"}],"predecessor-version":[{"id":19668,"href":"https:\/\/medicarereport.org\/index.php?rest_route=\/wp\/v2\/posts\/19666\/revisions\/19668"}],"wp:attachment":[{"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=19666"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=19666"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medicarereport.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=19666"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}